Matthew L Freedman

Dana-Farber Cancer Institute

NIH Rank #4834
  • Program Leader
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2.1M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#4,834
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.1M across 4 grants · National rank #4834.

Top grants by award amount

Matthew L Freedman's NIH grant portfolio, ranked by award amount.

  • 5R01CA251555-04R01
    Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches
    $641.1K
    award amount
  • 5R01CA262577-03R01
    Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies
    $640.3K
    award amount
  • 7R01CA259058-03R01
    Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci
    $599.2K
    award amount
  • 5P50CA272390-02P50
    DF/HCC Prostate SPORE
    $237.8K
    award amount

Affiliations

Institutions that have administered grants for Matthew L Freedman.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Dana-Farber Cancer Institute
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4834
  6. 2024
    Entered Top 25% Nationally
    Ranked #4834
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions